Patient

P2B-006

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)

consented 2012-05-05

State Health Centre Oncology Department (Budapest, Hungary)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

mild assessed 2012-08-13

Grade 1 decreased appetite with onset in cycle 5 (2012-08-13); assessed as not related to study drug (not related); resolved 2012-09-09.

severe assessed 2012-07-09

Grade 3 neutropenia with onset in cycle 3 (2012-07-09); assessed as related to study drug (probable); resolved 2012-07-19.

moderate assessed 2012-06-29

Grade 2 vomiting with onset in cycle 3 (2012-06-29); assessed as not related to study drug (not related); resolved 2012-06-30.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users